Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Webinar: "Seeking Best Practices in Classifier Construction and Testing"
Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.
Episode 15 with Professor Ludwig Kappos on the DECIDE trial of daclizumab versus interferon ë_-1a
Secondary Progressive Multiple Sclerosis: Definition and Measurement.
Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial.
Optical Coherence Tomography: A Potential Noninvasive Follow-up Tool in Multiple Sclerosis.
Novartis drug Gilenya® shows long-term efficacy and safety according to new data from extension of phase III head-to-head study
Brain reserve against physical disability progression over 5 years in multiple sclerosis.
Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine.
Effects of fumaric acids on cuprizone induced central nervous system de- and remyelination in the mouse.
Multiple sclerosis: pathogenesis and treatment.
Relationship between disease-modifying therapy and depression in multiple sclerosis.
Episode 14 with Professor Gavin Giovannoni on the Epstein-Barr Virus (EBV).
Treatment patterns in disease-modifying therapy for patients with multiple sclerosis in the United States.
Dimethyl fumarate for multiple sclerosis.
Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.
[Pharmacoeconomic analysis of the efficacy of natalizumab in relapsing-remitting multiple sclerosis].
Interleukin-1beta promotes repair of the CNS.
Firategrast
Primary results of DECIDE: a randomized, double-blind, double-dummy, active-controlled trial of daclizumab HYP vs. Interferon β-1a in RRMS patients
Extraocular Source of Oligodendrocytes Contribute to Retinal Myelination and Optokinetic Responses in Zebrafish.
Regulation of brain endothelial barrier function by microRNAs in health and neuroinflammation.
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis.
The differential diagnosis of neurological diseases by fractionating electrophoretically the CSF gamma-globulins.
Breastfeeding and multiple sclerosis relapses: a meta-analysis.

Pages